Audit of plastic surgeons understanding of pathology reports of skin neoplasia

Similar documents
Protocol applies to melanoma of cutaneous surfaces only.

For additional information on meeting the criteria for Mohs, see Appendix 2.

Malignant tumors of melanocytes : Part 3. Deba P Sarma, MD., Omaha

This is a repository copy of Easily missed? Amelanotic melanoma. White Rose Research Online URL for this paper:

CLINICAL EFFECTIVENESS

Maligna Melanoma and Atypical Fibroxanthoma: An Unusual Collision Tumour G Türkcü 1, A Keleş 1, U Alabalık 1, D Uçmak 2, H Büyükbayram 1 ABSTRACT

Dermatology for the PCP Deanna G. Brown, MD, FAAD Susong Dermatology Consulting Staff at CHI Memorial

DIRECTED WORKPLACE-BASED ASSESSMENTS BY STAGES OF TRAINING AND OPTIONAL PACKAGES

Skin Cut Up D R R O K I A H A L I C O N S U L T A N T D E R M A T O P A T H O L O G I S T S T H

Desmoplastic Melanoma R/O BCC. Clinical Information. 74 y.o. man with lesion on left side of neck r/o BCC

Proposal for a 2-stage RCT in high risk primary SCC: COMMISSAR Catherine Harwood Barts Health NHS Trust / QMUL

Melanoma Update: 8th Edition of AJCC Staging System

A PRACTICAL APPROACH TO ATYPICAL MELANOCYTIC LESIONS BIJAN HAGHIGHI M.D, DIRECTOR OF DERMATOPATHOLOGY, ST. JOSEPH HOSPITAL

PanMidlands Ocular Cancer Pathway March 2008 Approved by The Midland Oculoplastic Surgery Society

1. Written information to patient /GP: fax ASAP to GP & offer copy of consultation letter.

Activity Report March 2013 February 2014

Melanoma Case Scenario 1

Identifying Skin Cancer. Mary S. Stone MD Professor of Dermatology and Pathology University of Iowa Carver College of Medicine March, 2018

BRITISH ASSOCIATION OF DERMATOLOGISTS WORKING PARTY REPORT ON SETTING STANDARDS FOR MOHS MICROGRAPHIC SURGERY SERVICES

أملس عضلي غرن = Leiomyosarcoma. Leiomyosarcoma 1 / 5

Male Female Both sexes Male Female Both sexes FIVE-YEAR SURVIVAL ( )

Clinical Pathological Conference. Malignant Melanoma of the Vulva

Melanoma Case Scenario 1

COLORECTAL PATHWAY GROUP, MANCHESTER CANCER. Guidelines for the assessment of mismatch. Colorectal Cancer

COLORECTAL PATHWAY GROUP, MANCHESTER CANCER. Guidelines for the assessment of mismatch. Colorectal Cancer

Melanoma. Consultation on draft guideline - stakeholder comments. Comments to be submitted before 5pm on Friday 13 March 2015

Dermatopathology: The tumor is composed of keratinocytes which show atypia, increase mitoses and abnormal mitoses.

David B. Troxel, MD. Common Medicolegal Situations: Misdiagnosis of Melanoma

Head and Neck Cancer surgeon level data - first report. Queen Victoria Hospital NHS Foundation Trust

Da Costa was the first to coin the term. Marjolin s Ulcer: A Case Report and Literature Review. Case Report. Introduction

Periocular skin cancer

Guideline for the Management of Patients Suitable for Immediate Breast Reconstruction

Colon and Rectum. Protocol revision date: January 2005 Based on AJCC/UICC TNM, 6th edition

Melanoma-Back to Basics I Thought I Knew Ya! Paul K. Shitabata, M.D. Dermatopathologist APMG

Modalities of Radiation

Department of Dermatology, Queen Margaret & Victoria Hospitals

The Plastic Surgery See and Treat Skin Cancer Clinic (SATSKIN)

Primary Cutaneous Melanoma Pathology Reporting Proforma DD MM YYYY. *Tumour site. *Specimen laterality. *Specimen type

West Midlands Sarcoma Advisory Group

PROTOCOL SENTINEL NODE BIOPSY (NON OPERATIVE) BREAST CANCER - PATHOLOGY ASSESSMENT

Case Report A Rare Cutaneous Adnexal Tumor: Malignant Proliferating Trichilemmal Tumor

WHAT DOES THE PATHOLOGY REPORT MEAN?

Update on 8 th Edition Cutaneous AJCC Staging of Primary Cutaneous Melanoma. Michael T. Tetzlaff MD, PhD

Malignant Melanoma Care Pathway

MECHANISMS OF HUMAN DISEASE: LABORATORY SESSION PATHOLOGY OF THE SKIN LAB. Friday, February 12, :30 am 11:00 am

Small Intestine. Protocol revision date: January 2005 Based on AJCC/UICC TNM, 6 th edition

GLUT-1: an extra diagnostic tool to differentiate between haemangiomas and vascular malformations q

RECTAL CANCER APPARENT COMPLETE RESPONSE (acr) AFTER LONG COURSE CHEMORADIOTHERAPY

Skin cancer excision performance in Scottish primary and secondary care:

Basal cell carcinoma 5/28/2011

Histopathology of Melanoma

Uveal Melanoma. Protocol applies to malignant melanoma of the uvea.

Histopathology: skin pathology

University College Hospital. Mohs micrographic surgery. Dermatology Services

Glenn D. Goldman, MD. Fletcher Allen Health Care. University of Vermont College of Medicine

Poor Outcomes in Head and Neck Non-Melanoma Cutaneous Carcinomas

Greater Manchester & Cheshire Guidelines for Pathology Reporting for Oesophageal and Gastric Malignancy

BCC follow up audit. South West Public Health Observatory

Dermatopathology. Dr. Rafael Botella Estrada. Hospital La Fe de Valencia

Breslow Thickness and Clark Level Evaluation in Albanian Cutaneous Melanoma

Tracking skin cancers and melanoma at the microscopic level

Skin SSG (Anglia East & Anglia West)

Guideline for the Diagnosis of Breast Cancer

Skin lesions suspicious for melanoma: New Zealand excision margin guidelines in practice

JAM ACAD DERMATOL VOLUME 76, NUMBER 2. Research Letters 351

LCA Lung Clinical Forum. 21 st October 2014

Polypoid Melanoma, A Virulent Variant of the Nodular Growth Pattern

Guideline for the Management of Vulval Cancer

Melanoma and Dermoscopy. Disclosure Statement: ABCDE's of melanoma. Co-President, Usatine Media

Protocol for the Examination of Specimens From Patients With Primary Malignant Tumors of the Heart

Case Scenario 1 Worksheet. Primary Site C44.4 Morphology 8743/3 Laterality 0 Stage/ Prognostic Factors

Diagnostics guidance Published: 11 November 2015 nice.org.uk/guidance/dg19

making a referral for breast imaging Standard Operating Procedure

PATHOLOGY GROUP GUIDELINES FOR THE EXAMINATION AND REPORTING OF COLORECTAL CANCER SPECIMENS

Periocular Malignancies

Quality ID #397: Melanoma Reporting National Quality Strategy Domain: Communication and Care Coordination

Faster Cancer Treatment Indicators: Use cases

SEBACEOUS NEOPLASMS. Dr. Prachi Saraogi Clinical Fellow in Dermatology

Dr Stephen Hayes Associate Specialist in Dermatology University Hospital Southampton

Technicians & Nurses Program

Merkel Cell Carcinoma: Not Just Another Skin Cancer

Dermoscopy: Recognizing Top Five Common In- Office Diagnoses

Benign and malignant epithelial lesions: Seborrheic keratosis: A common benign pigmented epidermal tumor occur in middle-aged or older persons more

Approach to Core Biopsy Specimens

Common Benign Lesions and Skin Cancers. 22nd May 2015 Dr Mark Foley

Measure #397: Melanoma Reporting National Quality Strategy Domain: Communication and Care Coordination

Whitney A. High, MD, JD, MEng

FINALIZED SEER SINQ QUESTIONS

Research Article Melanoma in Buckinghamshire: Data from the Inception of the Skin Cancer Multidisciplinary Team

Improving Outcomes for People with Sarcoma

World Journal of Colorectal Surgery

Kidney Case 1 SURGICAL PATHOLOGY REPORT

Nonmelanoma skin cancers

Update on Cutaneous Mesenchymal Tumors. Thomas Brenn

When in doubt, ask an expert

Neoplasms of the Heart, Pericardium, and Great Vessels Histopathology Reporting Guide

Fixing footcare in Sheffield: Improving the pathway

Interesting Case Series. Aggressive Tumor of the Midface

CANCER REPORTING IN CALIFORNIA: ABSTRACTING AND CODING PROCEDURES California Cancer Reporting System Standards, Volume I

Transcription:

The British Association of Plastic Surgeons (2004) 57, 134 138 Audit of plastic surgeons understanding of pathology reports of skin neoplasia Y.S. Lau a, S.K. Suvarna b, *, L. Kangesu a, A. Mosahebi a a St Andrews Centre for Plastic Surgery and Burns, Broomfield Hospital, Court Road, Chelmsford CM1 7ET, UK b Department of Histopathology, Northern General Hospital NHS Trust, Herries Road, Sheffield S5 7AU, UK Received 21 March 2003; accepted 28 November 2003 KEYWORDS Skin neoplasia; Histopathology; Pathology; Minimum dataset Summary This audit was set up to investigate Plastic Surgeons perception of minimum standards of reporting of skin neoplasia at the time of publication of the Royal College of Pathologists guidelines. Eight histopathology case reports of skin neoplasia were formulated; four had the minimum information required and four had vital information omitted. Surgeons were asked to evaluate and suggest management. Marks were allocated for awareness of substandard reporting and for patient management. Fortythree out of 60 questionnaires were returned. Consultants had a significantly higher total score compared to the other grades ðp, 0:05Þ: A high knowledge score was correlated with a high management score. However, awareness of minimum data was relatively poor across all grades. The majority of participants themselves were unaware of the new guidelines (38/43). Awareness of the guidelines and increased understanding of basic pathology should correct these weaknesses. Q 2004 The British Association of Plastic Surgeons. Published by Elsevier Ltd. All rights reserved. In the last decade, Plastic Surgeons have seen an increasing number of patients with skin neoplasia, due to an increase in incidence and greater public awareness. 1 Ideal patient management requires sound knowledge of the pathology in question in order to guide treatment options. Prognostic indicators 2 4 are well recognised within the literature both by Plastic Surgeons and Pathologists. The Royal College of Pathologists has produced evidence-based guidelines defining the minimum standards of reporting common skin cancers to prevent the proliferation of numerous diverse and *Corresponding author. Tel.: þ44-114-271-5016; fax: þ44-114-261-1034. E-mail address: s.k.suvarna@sheffield.ac.uk possibly conflicting local guidelines. 5 These proposals should be implemented for the following reasons: To achieve consistency in histopathology reporting with regards to terminology and content, in order to facilitate liaison at the multidisciplinary team level and collaboration between cancer centres and units. To aid patient management and treatment by providing minimum histopathological information necessary to assist decision-making. To provide accurate prognostic information. To create a common database for clinical audit, which will provide feedback to clinicians regarding their quality of treatment. S0007-1226/$ - see front matter Q 2004 The British Association of Plastic Surgeons. Published by Elsevier Ltd. All rights reserved. doi:10.1016/j.bjps.2003.11.029

Audit of plastic surgeons understanding of pathology reports of skin neoplasia 135 To create a common database for research and entry into clinical trials. To create a common database for epidemiological monitoring and detection of changing patterns of disease. Plastic Surgeons historically have had a good understanding of pathology reports. This audit was set up to assess the level of knowledge at the time of the publication of the minimum data standards, and to find out whether, they were aware of the new published guidelines. Methods Eight histopathology reports of common skin neoplasia were formulated by a single Consultant Histopathologist, such that four reports were considered to have the minimum information required for planning further management, and the other four reports had the minimum information omitted (Appendix 1). The pathology reports in the format of a questionnaire were distributed to a group comprising Plastic Surgeons and trainees. The questionnaire contained eight case reports. Each surgeon was asked to state whether, each report was satisfactory or deficient, to highlight the deficiency if it existed and to suggest appropriate management for the patient in question. Each case report carried a maximum of four points; two points were given for correctly deciding if the report contained sufficient information, and a score of 0 2 points were given for management. The scores were tabulated under the headings knowledge and management, respectively. The answers were marked against the standard answer provided by two of the authors (S.K.S./A.M.) (Appendix 2). Other Pathologists commentary is also given alongside the answers. Results A total of 60 questionnaires were distributed, of which 43 were returned, giving a responder rate of 72%. Eight participants completed the questionnaire just before formal publication of the guidelines; the remaining 35 participants completed the questionnaire just after guideline publication. The participants and nonresponders were divided into four groups according to grade, as shown in Tables 1a and b. Thirty-five participants stated they were unaware of the guidelines. Table 1a Grade Scores ranged from 6 to 26 out of a total of 32. The Consultant participants obtained a mean total score of 19.7 out of 32 (made up of knowledge score of 10.9 and management score of 8.8). Specialist Registrars in years 4 6 obtained a mean total score of 15.9 (knowledge score of 9.5 and management score 6.4). Specialist Registrars in years 1 3 obtained a mean total score of 13.6 (knowledge score of 9.0 and management score of 4.6). Senior House Officers obtained a mean total score of 13.9 (knowledge score 8.6 and management score 5.3). These results are tabulated in Table 2. Table 3 shows the performance of participants against each pathology report. Statistical analysis of the results using the Mann Whitney U-test shows a significantly higher total score in the Consultant group ðp, 0:05Þ compared to the other grades. There was no significant difference between the other groups. Discussion Distribution of grades of participants Consultant 10 Specialist Registrar (years 4 6) 15 Specialist Registrar (years 1 3) 14 Senior House Officer 4 The nature of modern cancer therapy demands considerable familiarity with the pathological basis of malignancy. A good knowledge of basic pathology is essential for making decisions regarding further management of all types of malignancies. Our results confirm this fact, showing that a high knowledge score correlated with a high management score. Consultants achieved a significantly higher total score than the other grades. However, we demonstrated disappointingly poor scores across all the grades. Although the sample size is small, we feel that it is sufficient to be representative. The performance of a large proportion of Table 1b Grade Distribution of grades of nonresponders Consultant 2 Specialist Registrar 6 Senior House Officer 9 n n

136 Y.S. Lau et al. Table 2 Mean scores obtained according to grade Grade Knowledge score (16) Management score (16) Total score (32) Consultant 10.9 8.8 19.7 Specialist Registrar (year 4 6) 9.5 6.4 15.9 Specialist Registrar (year 1 3) 9.0 4.6 13.6 Senior House Officer 8.6 5.3 13.9 participants fell short of the recommended standards. Out of the eight cases presented, only two were correctly managed by more than 50% of participants. The results of this audit might be argued to show that Plastic Surgeons had a poor knowledge base with regard to skin cancer reporting. However, it should be remembered that the audit was set up to deliberately enforce binary scoring (satisfactory/ unsatisfactory report) and therefore the results are not necessarily surprising. Certainly, many of the surgeons who were involved in the audit commented that they would have made contact with the Pathology Department upon receipt of such reports in order to clarify matters/seek further information directly with the Pathologist in question, indicative of good practice. No opportunity to record this was made available in the answer sheet, again forcing the surgeon to declare a polar view. The possibility of personal bias with regard to the production of the histopathology reports needs to be considered, since only one Pathologist was involved with the construction of the questionnaire. Since the audit, this questionnaire has been circulated amongst five other Consultant Histopathologists, two of whom have a particular interest in dermatological disease. Their comments and criticisms are indicated by italicised script alongside the standard answers. Conclusion Perfection in reporting standards and style is the aspiration of all good Histopathologists in the UK. Hitherto with variable training in different centres and with the individual needs of different clinical groups even within a single hospital it has been difficult to achieve standard reporting style and content. The introduction of the Royal College of Pathologists guidelines for skin cancer reporting, and indeed other neoplasia, have found considerable clarification with regard to the needs of clinicians today and those involved in strategic planning of healthcare resources for the future. Drawn up to promote good standards of care across the whole country, the guidelines are intended to promote the integration of care between medical specialties for the benefit of the patient. It was clear from initial analysis of the questionnaires that some Plastic Surgeons felt this was an unfair exercise given that it was done at the time of publication of the guidelines, and that no similar assay had been previously performed against Histopathologists. Although formal publication occurred in February 2002, hard copies reached the Pathology departments nationwide around April 2002, the guidelines had been widely discussed in the Royal College of Dermatologists and Plastic Table 3 Distribution of correct responses for each pathology report Pathology report Participants with the correct response for Deciding if report contained minimum information, n (%) Management, n (%) 1 28 (65) 19 (44) 2 27 (63) 29 (67) 3 43 (100) 20 (47) 4 24 (56) 14 (33) 5 27 (63) 15 (35) 6 19 (44) 10 (23) 7 17 (40) 22 (51) 8 26 (60) 15 (35)

Audit of plastic surgeons understanding of pathology reports of skin neoplasia 137 Surgeons before February 2002. It is stressed that this audit was simply a benchmark assessment of knowledge at the time of guideline publication, with the object to retest this knowledge base 2 years following guideline publication. Plastic Surgeons should familiarise themselves with the published standards in order to ensure a high quality of care for their patients. In addition, we recommend that more emphasis be drawn toward the education of trainees with regard to understanding basic pathology. With the implementation of these changes, a further monitoring will be undertaken to complete the audit cycle. 6 Appendix A Histopathology reports in questionnaire 1. This is a skin ellipse measuring 9 5 3mm 3, with a central 4 mm diameter papule. Histological examination confirms the presence of a 1.9 mm deep nodular basal cell carcinoma with a deep and peripheral margin clearance of 0.5 and 0.9 mm, respectively. 2. This is a skin ellipse measuring 19 10 mm 2 with a depth of 6 mm. Centrally there is a brown macule measuring 9 mm diameter. All the tissue has been examined in serial pieces revealing an invasive superficial spreading malignant melanoma, composed of nonpigmented epithelioid cells, that penetrates the dermis to a Breslow depth of 0.7 mm, Clark s level III. There is a mild host lymphoid reaction locally. The melanoma shows a mitotic rate of four mitoses per square mm. No blood or lymphatic vessel invasion is seen. No pre-existing nevus, satellite focus or ulceration is identified. Local excision clearance is complete with a deep margin of 3.1 mm and a lateral clearance of 2.3 mm. 3. This is a polypoid piece of skin measuring 9 7 6mm 3. Focal ulceration is noted. Histological examination reveals a moderate grade nonkeratinising squamous cell carcinoma. There is a mild host lymphoid reaction. No blood or lymphatic vessel invasion is seen. 4. This is an ovoid piece of skin measuring 22 30 mm 2 with a depth of 5 mm. Centrally there is an ulcerated grey tumour measuring 15 mm diameter maximum. The central tumour is an ulcerated Merkel cell carcinoma that shows positive staining with CK20 and dot positivity with cytokeratin 5.2. No blood or lymphatic vessel invasion is seen, but the tumour is noted to be present at the deep resection margin. The peripheral margin is clear of neoplasia. 5. This is a skin ellipse measuring 14 7mm 2 with a depth of 2 mm. All this tissue has been examined in serial pieces revealing a superficial basal cell carcinoma that is fully excised in the planes examined. 6. A strip of skin measuring 6 4 3mm 3. This incisional biopsy reveals part of a microcystic adnexal carcinoma. 7. This is a skin ellipse measuring 9 7mm 2 with a depth of 5 mm. Centrally there is a pink papule measuring 5 mm. Histological examination reveals a nodular cluster of lymphocytes within the dermal tissues, extending into the subcutis. Immunohistochemistry reveals both T and B-cell components with scattered CD21 cells and no staining for CD5 or CD10. Bcl-2 staining is equivocal. The appearances may represent lymphocytoma cutis, although this would require clinico-pathological correlation. 8. An ovoid piece of skin bearing tissue measuring 40 28 mm 2 with a depth of 10 mm this seen with an ulcerated beige tumour measuring 15 mm in maximum dimension. The tumour is a high-grade leiomyosarcoma that shows marked pleomorphism and a mitotic count of five mitoses per square millimetre. The tumour is clear of the peripheral boundary by 6 mm. There is a mild host lymphoid reaction. No lymphatic invasion is seen. Appendix B Answers used in marking questionnaires 1. Satisfactory. No deficiencies. Allows decision making regarding treatment. 2. Satisfactory. No deficiencies. Allows consideration of whether to proceed to wider clearance or wait-and-watch. Since the publication of the guidelines, it is noted that the phrase vertical growth phase should be used together with a gradation with regard to the lymphoid infiltrate. 3. Unsatisfactory. No size of tumour or clearance margins (deep and lateral), or the subtype of squamous cell carcinoma. Insufficient information for clinical decision making. 4. Unsatisfactory. No peripheral clearance of tumour stated. Allows decision making with regard to an aggressive sub-type carcinoma. Need for wide excision and dermatology multidisciplinary team (MDT) referral.

138 Y.S. Lau et al. 5. Unsatisfactory. No macroscopic measurements. Insufficient histological measurements defined. Insufficient data for review or follow-up. 6. Satisfactory. Measurements may not be relevant as this is only an incisional biopsy. Sufficient data to indicate aggressive sub-type carcinoma with associated clearance problems. May need MDT referral. Some Pathologists would grade this type of carcinoma and specifically mention perineural invasion of lymphatics if present/absent. 7. Satisfactory. The pathologist is querying whether specimen is a benign lymphoid proliferation or nonhodgkin s lymphoma. Further discussion with pathologist and other clinicians is needed to resolve management (dermatology and/or lymphoma MDT). Staging investigations need to be considered. Some aspects of this biopsy report are inaccurate/confusing with regard to the subtype of lymphoma/lymphoid population. This was deliberately used as an example following a recent medico-legal case. 8. Unsatisfactory. No deep clearance given; vascular invasion not quoted. Insufficient data for decision making, but needs referral to sarcoma MDT. References 1. Ko CB, Walton S, Keczkes K, Bury HP, Nicholson C. The emerging epidemic of skin cancer. Br J Dermatol 1994;130: 269 72. 2. Masback A, Olsson H, Westerdahl J, Ingvar C, Jonsson N. Prognostic factors in invasive cutaneous malignant melanoma: a population-based study and review. Melanoma Res 2001;11:435 45. 3. Cherpelis BS, Marcusen C, Lang PG. Prognostic factors for metastasis in squamous cell carcinoma of the skin. Dermatol Surg 2002;28:268 73. 4. Motley R, Kersey P, Lawrence C. Multiprofessional guidelines for the management of the patient with primary cutaneous squamous cell carcinoma. Br J Dermatol 2002;146:18 25. 5. Minimum dataset for the histopathological reporting of common skin cancers. Royal College of Pathologists Working Group on Cancer Services, 2002 (website www.rcpath.org). 6. National Institute for Clinical Excellence, Principles for best practice in clinical audit. Oxford: Radcliffe Medical Press; 2002.